Enclomiphene

Mechanism of Action

Enclomiphene works as a selective estrogen receptor modulator (SERM) with a distinct mechanism that differs from its mixed isomer counterpart, clomiphene citrate. However, the available evidence provides limited specific detail about enclomiphene's molecular mechanisms.

Primary Mechanism:
Based on the available literature, enclomiphene appears to function primarily as an estrogen receptor antagonist in the hypothalamus and pituitary gland. By blocking estrogen receptors in these key regulatory centers, enclomiphene interrupts the normal negative feedback that estrogen exerts on gonadotropin release. This leads to increased production and release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) from the pituitary gland.

Hormonal Cascade:
The increased LH and FSH levels then stimulate the gonads:

• In males, LH stimulates testosterone production by Leydig cells in the testes
• FSH supports spermatogenesis and overall testicular function
• This mechanism allows for preservation of fertility while addressing testosterone deficiency

Clinical Evidence:
The mechanism is supported by clinical observations showing testosterone increases following enclomiphene treatment. A retrospective case series documented serum testosterone changes after sublingual enclomiphene administration, though specific mechanistic details were not elaborated in the available evidence.

Limitations of Current Evidence:
The available research provides limited granular detail about enclomiphene's specific molecular binding properties, receptor selectivity profiles, or detailed pharmacodynamic pathways. Most mechanistic understanding appears to be extrapolated from the broader SERM class of medications and clinical outcomes rather than comprehensive molecular studies of enclomiphene specifically.

Note: This information is for educational purposes only and should not replace consultation with a healthcare provider for medical advice.